Olink Bioscience Appoints Sigma-Aldrich as Distributor of Duolink
News May 17, 2013
Olink Bioscience has announced the appointment of Sigma® Life Science, the innovative biological products and services business unit of Sigma-Aldrich Corporation, as distributor of the Duolink® In Situ product line in nearly all geographies worldwide for the research market.
The agreement will expand the market for Duolink In Situ by leveraging the industry-leading marketing, sales, support and distribution power of Sigma® Life Science.
“We believe our agreement will build awareness and develop the market for Duolink In Situ through the global sales and support organization that serves our growing customer base locally ”said Simon Fredriksson, CEO and President of Olink Bioscience.
Fredriksson continued, “The Sigma® Life Science product range for Cell Biology is extensive and a perfect context for customers interested in Duolink In Situ.”
“Duolink In Situ is a powerful addition to our portfolio of Proteomics products and will be readily available through the sigma-aldrich.com website", said Josef Zihlmann, Vice President, Marketing, Sigma Life Science.
Zihlmann continued, "The ability to visualize protein-protein interactions in unmodified cells under endogenous expression is a fundamental advance, and can provide enhanced insight into basic biology, disease-relevant signaling pathways, and potential therapeutic compounds that can manipulate those pathways”.
Interaction Mechanism for 'Boiled Noodle' Proteins IdentifiedNews
Even unstructured proteins can bind together with incredible strength using electrostatic attraction, a new study suggests.READ MORE
Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain TherapeuticsNews
The new Swiss company will operate in Lugano and Barcelona under the scientific management of Minoryx co-founder Dr Xavier Barril.READ MORE
Comments | 0 ADD COMMENT
World Advanced Therapies & Regenerative Medicine Congress
May 16 - May 18, 2018